Tin tức & Cập nhật
Xem bài viết Đa khoa
Xem
Chỉ hiển thị Multimedia

Gotistobart a chemo-free option for metastatic sqNSCLC
15 Apr 2026
bởiStephen Padilla
Gotistobart monotherapy elicits an improved and durable antitumour response with a meaningful survival benefit relative to docetaxel in patients with metastatic squamous nonsmall cell lung cancer (sqNSCLC) who experience disease progression on or after anti-PD-(L)1 treatment, as shown by the results of the stage 1 PRESERVE-003 phase III trial.
Gotistobart a chemo-free option for metastatic sqNSCLC
15 Apr 2026
Mavacamten reduces blood flow obstruction in adolescents with HCM
14 Apr 2026
bởiStephen Padilla
Treatment with mavacamten, compared with placebo, results in significantly greater reduction in left ventricular outflow tract (LVOT) obstruction over 28 weeks among adolescent patients with obstructive hypertrophic cardiomyopathy (HCM), as shown in the SCOUT-HCM trial.







